Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
In a flurry of activity, biopharma companies pulled off seven transactions in the last two weeks of March worth a combined $29 billion. The blitz indicates that 2026 will be a prime year for M&A and that the surge seen in the fourth quarter of 2025 was not a false alarm.
Resonate Group, an ambitious Nigerian indigenous company with global aspirations, that aligns her vision with strategic intent to provide innovative solutions and services in Oil & Gas, Maritime, Manufacturing, Finance, Steel, Healthcare, and Supply Chain sectors of the Nigerian economy...
